Voice Treatment for Parkinson's Disease

Completed · Not applicable

Conditions studied: Idiopathic Parkinson Disease

In brief

This study addresses several issues related to the clinical management of speech and voice disorders associated with Parkinson's disease. Two behavioral treatment programs, Lee Silverman Voice Treatment and SpeechVive, are assessed in their ability to improve communication in persons with Parkinson's disease.

Key facts

Study ID

NCT03700684

Run by

University of Massachusetts, Amherst

People needed

36

Starts

2018-09-19

Expected to finish

2022-11-30

Last updated by the study team

2023-05-30

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Parkinson's disease
• Problems with speech loudness due to Parkinson's disease
• No asthma or other respiratory problems
• No head, neck or chest surgery (Pacemaker surgery is okay)
• Non-smoking for the last 5 years
• Not currently participating in another treatment study
• Typical cognitive skills
• Free of symptoms of depression
• Unaided hearing in at least one ear
• No voice therapy or voice therapy maintenance within the last 12 months

You may not qualify if…

• Other neurological diseases, other than Parkinson's disease
• History of asthma or respiratory problems
• Head, neck or chest surgery
• Smoker within the last 5 years
• Currently involved in another treatment study
• Decreased cognition
• Symptoms of depression
• Wear a hearing aid in both ears
• Participated in voice therapy within the last 12 months.

Where it is running

• Purdue University — West Lafayette, Indiana, United States
• University of Massachusetts Amherst — Amherst, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.